IMM 20.3% 35.5¢ immutep limited

Absolutely correct. I read the Bell Potter analyst report on...

  1. 264 Posts.
    lightbulb Created with Sketch. 12
    Absolutely correct. I read the Bell Potter analyst report on Immutep 'Bell Potter - ASCO data further builds case for efti+Keytruda, with HNSCC looking more attractive' and they definitely are more excited re the accelerated pathway to approval in HNSCC
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
0.060(20.3%)
Mkt cap ! $515.6M
Open High Low Value Volume
36.0¢ 37.5¢ 33.5¢ $6.427M 18.03M

Buyers (Bids)

No. Vol. Price($)
1 50000 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 133736 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.